A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity

Clinical Immunology

Volumn 123, Issue 3, 2007, Pages 272-280

  Yun, Gong ^a   Tolar, Jakub ^a   Yerich, Anton K ^a   Marsh, Steven G E ^b,c   Robinson, James ^b   Noreen, Harriet ^d   Blazar, Bruce R ^a   Miller, Jeffrey S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Alloreactivity; HLA typing; Human; Killer immunoglobulin receptor; NK cells; Pyrosequencing

Indexed keywords

DNA; EPITOPE; HLA B ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN RECEPTOR; KILLER IMMUNOGLOBULIN RECEPTOR; KIR LIGAND; LIGAND; PRIMER DNA; RNA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOIMMUNITY; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EVALUATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NATURAL KILLER T CELL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PYROSEQUENCING; RELAPSE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; VALIDATION PROCESS;

ALLELES; BASE SEQUENCE; DATABASES, NUCLEIC ACID; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; INTERNET; ISOANTIGENS; KILLER CELLS, NATURAL; LIGANDS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSPLANTATION IMMUNOLOGY; USER-COMPUTER INTERFACE;

EID: 34249712880     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.01.011     Document Type: Article

References (31)

1. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M.F., and Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
2. Cooley S., McCullar V., Wangen R., Bergemann T.L., Spellman S., Weisdorf D.J., and Miller J.S. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 106 (2005) 4370-4376
3. Davies S.M., Ruggieri L., DeFor T., Wagner J.E., Weisdorf D.J., Miller J.S., Velardi A., and Blazar B.R. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 100 (2002) 3825-3827
4. Miller J.S., Soignier Y., Panoskaltsis-Mortari A., McNearney S.A., Yun G.H., Fautsch S.K., McKenna D., Le C., Defor T.E., Burns L.J., Orchard P.J., Blazar B.R., Wagner J.E., Slungaard A., Weisdorf D.J., Okazaki I.J., and McGlave P.B. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105 (2005) 3051-3057
5. Giebel S., Locatelli F., Lamparelli T., Velardi A., Davies S., Frumento G., Maccario R., Bonetti F., Wojnar J., Martinetti M., Frassoni F., Giorgiani G., Bacigalupo A., and Holowiecki J. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102 (2003) 814-819
6. Valiante N.M., and Parham P. Natural killer cells, HLA class I molecules, and marrow transplantation. Biol. Blood Marrow Transplant. 3 (1997) 229-235
7. Verheyden S., Schots R., Duquet W., and Demanet C. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 19 (2005) 1446-1451
8. Martin M.P., Gao X., Lee J., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S.J., and Carrington M. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31 (2002) 429-434
9. Marsh S.G.E., Parham P., and Barber L.D. The HLA Facts Book (2000), Academic Press, San Diego
10. Cook M.A., Milligan D.W., Fegan C.D., Darbyshire P.J., Mahendra P., Craddock C.F., Moss P.A.H., and Briggs D.C. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 103 (2004) 1521-1526
11. Fan Q.R., and Wiley D.C. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J. Exp. Med. 190 (1999) 113-124
12. Mandelboim O., Reyburn H.T., Sheu E.G., Gomez M.V., Davis D.M., Pazmany L., and Strominger J.L. The binding site of NK receptors on HLA-C molecules. Immunity 6 (1997) 341-350
13. Boyington J.C., Motyka S.A., Schuck P., Brooks A.G., and Sun P.D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405 (2000) 537-543
14. Fan Q.R., Long E.O., and Wiley D.C. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nature Immunology 2 (2001) 452-460
15. Robinson J., Waller M.J., Parham P., de Groot N., Bontrop R., Kennedy L.J., Stoehr P., and Marsh S.G.E. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31 (2003) 311-314
16. Rajagopalan S., and Long E.O. Understanding how combinations of HLA and KIR genes influence disease. J. Exp. Med. 201 (2005) 1025-1029
17. Miller J.S., and McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 98 (2001) 705-713
18. Pende D., Spaggiari G.M., Marcenaro S., Martini S., Rivera P., Capobianco A., Falco M., Lanino E., Pierri I., Zambello R., Bacigalupo A., Mingari M.C., Moretta A., and Moretta L. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 105 (2005) 2066-2073
19. Colonna M., and Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 286 (1995) 405-408
20. Ramon D., Braden M., Adams S., Marincola F.M., and Wang L. Pyrosequencing™: a one-step method for high resolution HLA typing. J. Transl. Med. 1 (2003) 9
21. Marsh S.G.E., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., Geraghty D.E., Hansen J.A., Hurley C.K., Mach B., Mayr W.R., Parham P., Petersdorf E.W., Sasazuki T., Schreuder G.M.T., Strominger J.L., Svejgaard A., Terasaki P.I., and Trowsdale J. Nomenclature for factors of the HLA system, 2004. Tissue Antigens 65 (2005) 301-369
22. Nordstrom T., Ronaghi M., Forsberg L., de Faire U., Morgenstern R., and Nyren P. Direct analysis of single-nucleotide polymorphism on double-stranded DNA by pyrosequencing. Biotechnol. Appl. Biochem. 31 (2000) 107-112
23. Robinson J., Waller M.J., Stoehr P., and Marsh S.G.E. IPD-the Immuno Polymorphism Database. Nucleic Acids Res. 33 (2005) 523-526
24. Hochberg E.P., Miklos D.B., Neuberg D., Eichner D.A., McLaughlin S.F., Mattes-Ritz A., Alyea E.P., Antin J.H., Soiffer R.J., and Ritz J. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood 101 (2003) 363-369
25. Wu C.J., Hochburg E.P., Rogers S.A., Kutok J.L., Biernacki M., Nascimento A.F., Marks P., Bridges K., and Ritz J. Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation. Exp. Hematol. 10 (2003) 924-933
26. Thiede C. Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers. Am. J. Pharmacogenomics 4 (2004) 177-187
27. Anthony Nolan Research Institute, www.anthonynolan.org.uk/HIG/lists/null.html Null and alternatively expressed alleles named as of October 2006.
28. Masuda K., Hiraki A., Fujii N., Watanabe T., Tanaka M., Matsue K., Ogama Y., Ouchida M., Shimizu K., Ikeda K., and Tanimoto M. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts. Cancer Sci. 98 (2006) 102-108
29. Demanet C., Mulder A., Deneys V., Worsham M., Claas F., and Ferrone S. Downregulation of HLA-A and Bw6, but not Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?. Blood 103 (2004) 3122-3130
30. Ronaghi M. Pyrosequencing sheds light on DNA sequencing. Genome Res. 11 (2001) 3-11
31. D. Middleton, L. Menchaca, H. Rood, R. Komerofsky, www.allelefrequencies.net New Allele Frequency Database, Tissue Antigens 61 (2003) 403-407.